Polycystic Ovary Syndrome and Risk of Type 2 Diabetes, Coronary Heart Disease, and Stroke
The DOI matches its Crossref record; 49 of the 53 references it cites were found in a registry or an index.
Abstract
Polycystic ovary syndrome (PCOS) has been associated with diabetes and cardiovascular disease; however, whether the relationship is causal is uncertain. We conducted a two-sample Mendelian randomization study to investigate the associations of PCOS with type 2 diabetes, coronary heart disease (CHD), and stroke. Association between PCOS and diabetes risk was examined in European and Asian cohorts, both sex specific and sex combined. Causal effects of PCOS on risks of CHD and stroke were evaluated in European cohorts. Stroke was analyzed as any stroke as well as four subtypes of stroke (ischemic, large artery, cardioembolic, small vessel). We found no association of genetically predicted PCOS with risk of diabetes, CHD, or stroke. This suggests that PCOS in and of itself does not increase the risk of these outcomes. Other features of PCOS (obesity, elevated testosterone, low sex hormone binding globulin) may explain the association between PCOS and cardiometabolic diseases. In light of these results, efforts to prevent cardiometabolic complications in PCOS should focus on women with high-risk features rather than all women with PCOS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Obesity, insulin resistance, and dyslipidemia are common clinical features in women with PCOS and increase the risk for cardiometabolic diseases and reproductive cancers by ≥50% [3]”
From Availability and Use of Digital Technology Among Women With Polycystic Ovary Syndrome: Scoping Review (2025) · cites this paper as [3]
Citations
Cites
Bowden, J., Davey Smith, G., & Burgess, S. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv080 · Cited by 9,816 · cited 6×
“In all cases, the MR-Egger intercepts were not different from zero, indicating absence of directional pleiotropy.”
BackgroundMethodInfluentialBowden, J., Davey Smith, G., Haycock, P. C., & Burgess, S. (2016) · Genetic Epidemiology · doi:10.1002/gepi.21965 · Cited by 8,922 · cited 2×
“The weighted median approach can provide a consistent causal effect estimate as long as at least 50% of the information contributing to the analysis comes from valid instrumental variables (20).”
BackgroundMethodThe MR-Base platform supports systematic causal inference across the human phenome
Hemani, G., Zheng, J., Elsworth, B., Wade, K. H., Haberland, V., Baird, D., Laurin, C., Burgess, S., Bowden, J., Langdon, R., et al. (2018) · eLife · doi:10.7554/elife.34408 · Cited by 7,959 · cited 2×
“We used R 3.6.3 software and the R package TwoSampleMR (22) for the analyses.”
MethodInfluentialBurgess, S., Bowden, J., Fall, T., Ingelsson, E., & Thompson, S. G. (2017) · Epidemiology · doi:10.1097/ede.0000000000000559 · Cited by 2,017
A framework for the investigation of pleiotropy in two‐sample summary data Mendelian randomization
Bowden, J., Del Greco M, F., Minelli, C., Davey Smith, G., Sheehan, N., & Thompson, J. (2017) · Statistics in Medicine · doi:10.1002/sim.7221 · Cited by 1,887 · cited 1×
“Primary MR analyses were conducted with the inverse variance weighted (IVW) method with random effects (18).”
MethodMahajan, A., Taliun, D., Thurner, M., Robertson, N. R., Torres, J. M., Rayner, N. W., Payne, A. J., Steinthorsdottir, V., Scott, R. A., Grarup, N., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0241-6 · Cited by 1,744
Legro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.165 · Cited by 1,743 · cited 1×
“However, some studies that did attempt to match for or statistically adjust for BMI reported positive association between PCOS and diabetes (25,31,32).”
ResultMalik, R., Chauhan, G., Traylor, M., Sargurupremraj, M., Okada, Y., Mishra, A., Rutten-Jacobs, L., Giese, A.-K., van der Laan, S. W., Gretarsdottir, S., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0058-3 · Cited by 1,599
Bowden, J., Del Greco M., F., Minelli, C., Davey Smith, G., Sheehan, N. A., & Thompson, J. R. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw220 · Cited by 1,565
Pulit, S. L., Stoneman, C., Morris, A. P., Wood, A. R., Glastonbury, C. A., Tyrrell, J., Yengo, L., Ferreira, T., Marouli, E., Ji, Y., et al. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddy327 · Cited by 1,163
Cited by
Items 201–244 of 244
Chen, S., Guo, Z., & Yu, Q. (2024) · Figshare · doi:10.6084/m9.figshare.24558199
Jiang, H., Chen, L., Huang, N., Shi, H., Chi, H., Yang, R., Long, X., & Qiao, J. (2024) · Figshare · doi:10.6084/m9.figshare.26604166
Polycystic ovary syndrome – burden and adverse outcomes
Subramanian, A. (2023) · University of Birmingham Institutional Research Archive (University of Birmingham)
The Quality of Life of Menopausal Women With Polycystic Ovary Syndrome
Stephens, G. (2023) · ScholarWorks (Walden University) · Cited by 3
Mo, T., Qiu, Y., He, S., Wang, G., Li, B., Shen, Q., Nie, X., Wei, J., Li, N., Pang, B., et al. (2025) · Journal of Ovarian Research · doi:10.1186/s13048-025-01918-6 · Cited by 1
“Individuals with PCOS who are obese or have elevated free testosterone (FT) levels are also more susceptible to developing type 2 diabetes, as well as cardiovascular and cerebrovascular diseases [16, 76].”
Relationship between leptin receptor and TNF-α in obesity and polycystic ovary syndrome
Attia, O. M., & Abdelmoaty, A. A. A. (2025) · Asia-Pacific Journal of Surgical & Experimental Pathology · doi:10.32948/ajsep.2025.06.20
Polycystic ovary syndrome and cardiovascular disease risk
Друк, И. В., Друк, И. В., & Мамедов, М. Н. (2026) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2025-3183
From “Disease Treatment” to “Health Management”: Constructing a Lifespan Health Model for PCOS
黄亚玲 (2026) · Traditional Chinese Medicine · doi:10.12677/tcm.2026.152076
A Lifecourse Perspective on Polycystic Ovary Syndrome (PCOS): Bridging Gaps in Research and Practice
(2026) · Frontiers research topics · doi:10.3389/978-2-8325-7544-4
Ryšys tarp nutukimo ir atsparumo insulinui moterims, sergančioms PCOS
Risman, R. I. (2025) · Lithuanian University of Health Sciences
Xu, L., Zhang, S., Shi, W., & Zou, S. (2026) · International Journal of Women s Health · doi:10.2147/ijwh.s586268
Aumento do risco cardiovascular em mulheres com síndrome do ovário policístico
Caetano, G. P., de Castro, K. C. E., & Amâncio, N. D. F. G. (2022) · Femina · doi:10.61622/0100-7254505202207 · Cited by 6
“Nessa mesma perspectiva, Zhu et al. (4) afirmam que a hiperandrogenemia é também uma característica dia-betogênica potencial da SOP.”
Kandasamy, S., Amutha, D. P., & Shyamala, K. (2026) · International Journal of Drug Delivery Technology · doi:10.25258/ijddt.16.37s.74
Nasrullayeva, S. R., Nasrullayeva, M. R., Ismailova, A. S., Isalova, S. M., Dobychina, A. Y., Magomedova, N. G., Omarova, D. U., & Kazikhanov, A. G. (2026) · Genetics and Molecular Research · doi:10.4238/h3811y36
Arshad, F., Beigh, N. T., Alcheikh, N., & Naikoo, G. A. (2026) · Sensors and Actuators Reports · doi:10.1016/j.snr.2026.100481 · Cited by 1
Lang, T., & Yang, Y. (2026) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2026.107090
Pan, Y., Jiang, J., & Sun, F. (2026) · International Journal of Women s Health · doi:10.2147/ijwh.s598204
Genetically Predicted Causal Relationship Between Polycystic Ovary Syndrome and Preeclampsia
Xue, G., Zhou, X., Zhang, H., Wang, J., & Song, X. (2026) · International Journal of Endocrinology · doi:10.1155/ije/5536687
“…[20]; Cao et al. analyzing the causal association between PCOS and diferent subtypes of breast cancer [21]; and Zhu et al. concluding that PCOS itself does not increase the risk of Type 2 diabetes, coronary heart disease, and stroke, but rather emphasizes the high-risk characteristics of PCOS [22].”
Wright, P. J., & Corbett, C. F. (2026) · Pilot and Feasibility Studies · doi:10.1186/s40814-026-01887-7
“PCOS clinical features include obesity, insulin resistance, and dyslipidemia, all increasing risk of cardiometabolic diseases [4, 5] and reproductive cancers [6] by up to 50%.”
Liu, X., Bi, L., Jin, Q., Hu, H., Liu, W., & Cheng, L. (2026) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0000000000001323
Noland, M. J. O., & Olfert, M. D. (2026) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph23081085
“PCOS has been associated with adverse health conditions like obesity, diabetes, dyslipidemia, cardiovascular disease, sleep apnea, nonalcoholic fatty liver disease, and depression [5].”
Du, S., Dai, D., Pan, W., Zhou, J., & Wang, K. (2026) · Medicine · doi:10.1097/md.0000000000050366
“[60] To further explore the underlying mechanisms, Cao et al used multivariable MR to examine the mediating roles of PCOS-related clinical traits in the pathway from PCOS to ER-positive breast cancer.”
Shaikh, F., Kumari, P., Patel, N., Soni, S., & Mansuri, M. M. (2026) · Clinical Epidemiology and Global Health · doi:10.1016/j.cegh.2026.102460
Moore, M. E., Hirani, R., Khessib, S., Chirumamilla, A. P., Frishman, W. H., & Etienne, M. (2026) · Cardiology in Review · doi:10.1097/crd.0000000000001453
Albaik, M., McGuigan, F. E., Altyar, A. E., Khan, J. A., & Åkesson, K. (2026) · Archives of Osteoporosis · doi:10.1007/s11657-026-01707-8
“Insulin resistance is a key feature of PCOS, contributing to the pathogenesis of the syndrome and its associated complications, such as type 2 diabetes and cardiovascular disease [4].”
Understanding The Influencing Factors in The Onset of PCOS: A Review
Kurniawati, E. Y. (2025) · Jurnal Keperawatan Komplementer Holistic · doi:10.12345/jkkhc.v3i1.79 · Cited by 1
Association of CCR5 gene polymorphism with incidence of polycystic ovarian syndrome.
Abdulrazzaq, F. A., & Al-Obaidi, Z. F. H. (2025) · Iraqi Journal of Bioscience and Biomedical
Baba, S. S., Babu, C. J., & Abdussami, M. (2026) · IEEE World Conference on Applied Intelligence and Computing (AIC) · doi:10.1109/aic70896.2026.11716822
“Several techniques for data preprocessing were included for improving learning performance, including normalization, missing value generation and feature selection [17-18].”
Polycystic Ovarian Syndrome and Diabetes Mellitus: A Bidirectional Endocrine Disorder
Barman, I., Malik, S., Bora, J., Sharma, T., Sarma, J., Priya, S., Rustagi, S., Thapliyal, S., Deshwal, R. K., Ray, S., et al. (2026) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/3486
Potential links between PCOS/PMOS and Alzheimer disease and related dementias
Amiri, M., Hamidi, A. K., Farkas, D. L., Buyalos, R. P., & Azziz, R. (2026) · Journal of the Endocrine Society · doi:10.1210/jendso/bvag206
Shaikh, F., Kumari, P., Patel, N., Soni, S., & Mansuri, M. M. (2026) · Clinical Epidemiology and Global Health · doi:10.1016/j.cegh.2026.102509
Cheng, X., Li, Y., Zhu, M., 蔡亞潔, Wei, N., Liu, Y., & Liu, Y. (2026) · Chinese Herbal Medicines · doi:10.1016/j.chmed.2026.10.002
Bdeir, R., Al‐Sawalha, N. A., Rawashdeh, H., Malkawi, R., & Alrousan, O. (2026) · Annals of Medicine · doi:10.1080/07853890.2026.2749018
Metadata
- Authors
- Zhu, T., Cui, J., & Goodarzi, M. O.
- Affiliations
- Cedars-Sinai Medical Center (US)
- Corresponding author
- Goodarzi, Mark O.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2020-11-06
- Volume
- 70
- Issue
- 2
- Pages
- 627-637
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W3095084496
- Cited by
- 226
- References
- 53
- Citations by year
- 2026: 24 · 2025: 41 · 2024: 36 · 2023: 83 · 2022: 29 · 2021: 13
- FWCI
- 27.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- polycystic ovary syndrome, type 2 diabetes, coronary artery disease, stroke, cardiometabolic disease, causal inference, genetic risk prediction, sex differences, stroke subtypes, obesity, testosterone, sex hormone-binding globulin
- MeSH terms
- Adult, Coronary Disease, Diabetes Mellitus, Type 2, Female, Humans, Polycystic Ovary Syndrome, Risk, Comorbidity, Case-Control Studies, Stroke, Mendelian Randomization Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.